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Challenges of Older Patients’ Knowledge About Warfarin Therapy 
Abstract 
Objective: To review the challenges of warfarin education for older patients (aged 65 years or older) in 
terms of knowledge, access to warfarin education, and education resources. Methods: A quasi-
systematic review of the literature was performed via electronic database searches (eg, Medline, Embase, 
Cumulative Index to Nursing and Allied Health Literature, International Pharmaceutical Abstracts, 
Meditext, and Google Scholar) from 1990 to May 2011. Results: The 62 articles reviewed found that 
improved patient knowledge results in better anticoagulation control. The review also found that between 
50% and 80% of older patients have inadequate knowledge about the basic aspects of warfarin therapy 
(eg, action, benefits and risks, interactions with other drugs or foods, international normalized ratio 
management). Demographic factors, such as advancing age, lower family income, and limited health 
literacy, were found to inversely affect patients’ warfarin knowledge, and access to warfarin education 
and information resources were often suboptimal in different practice settings. Finally, a number of 
educational strategies and resources that could be readily incorporated to improve the effectiveness of 
current warfarin education programs were extracted from the review. Conclusion: This comprehensive 
review highlights that education about warfarin in older patients is currently suboptimal and may in part 
contribute to poor therapeutic outcomes. This review article also acknowledges the need to identify, 
target, and develop educational strategies and resources to further improve older patients’ knowledge 
about their warfarin therapy. 
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Title: Challenges of older patients’ knowledge about warfarin therapy  
 
Abstract [Word count: 211, Limit 250] 
Objective: To review the challenges in warfarin education for older patients (aged 65 
years or more) in terms of knowledge, access to warfarin education and education 
resources.   
Methods: A quasi-systematic review of the literature was performed via electronic 
database searches (e.g., Medline, Embase, CINAHL, International Pharmaceutical 
Abstracts (IPA), Meditext and Google Scholar) from 1990 to May 2011. 
Results: The 62 articles reviewed found that improved patient knowledge results in better 
anticoagulation control, however between 50-80% of older patients have inadequate 
knowledge about the basic aspects of warfarin therapy (e.g., action, benefits and risks, 
interactions with drugs or foods, INR management). Demographic factors, such as 
advancing age, lower family income, limited health literacy, were found to inversely affect 
patients’ warfarin knowledge and access to warfarin education and information resources 
was often suboptimal in different practice settings. Finally, a number of educational 
strategies and resources which could be readily incorporated to improve the effectiveness 
of current warfarin education programmes were extracted from the review. 
Conclusion: This comprehensive review highlights that education about warfarin in older 
patients is currently suboptimal and may in part contribute to poor therapeutic outcomes.  
This review paper also acknowledges the need to identify, target and develop educational 
strategies and resources to improve older patients’ knowledge about their warfarin 
therapy. 
Keywords: warfarin, oral anticoagulant, patient education, patient counselling, medicine 
information, patient knowledge 
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Introduction [Word count: 4,935; Limit 5,000] 
Warfarin is currently the most widely prescribed oral anticoagulant in the world.1 Whilst 
alternative agents have recently become available for the management of thromboembolic 
complications, they are not without risks and are associated with significant treatment 
costs1-3 which is why  warfarin will remain  a primary therapeutic option.4  The continued 
use of warfarin is challenged by its complex pharmacology and inherent risk of adverse 
outcomes, which mandates that routine therapeutic drug monitoring is undertaken to 
ensure safe and effective therapy.5-8  
 
Individuals most likely to benefit from warfarin therapy are generally older patients with 
chronic risk factors for thromboembolism requiring long-term or indefinite oral 
anticoagulation therapy (OAT), for instance in the management of atrial fibrillation.9, 10 
Despite abundant evidence to support its use, various studies have reported that warfarin 
therapy remains underutilised in this group of patients.6, 7, 11-16 Some of the most 
frequently cited, barriers to warfarin use by physicians include uncertainty of patient 
compliance with monitoring, dietary implications and fear of hemorrhagic complications. 
Experts suggest that the use of oral anticoagulants can be promoted by increasing both 
patient and physician education about the potential barriers.10  
 
Warfarin is a major contributor to potentially preventable drug-related adverse events,17, 18 
partly due to inadequate patient knowledge.19 Older individuals are particularly at greater 
risk of experiencing serious adverse events from oral anticoagulation therapy, highlighting 
the critical balance between risk and benefit.1 Clinicians have previously cited a reluctance 
to prescribe warfarin due to its impact on diet, drug interactions and need for monitoring,16 
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all of which relies on patient adherence and treatment instructions, and which is therefore 
dependent on effective patient education.20, 21   
 
This paper cites important issues in the published literature relating to older patients’ 
(aged 65 years or more) knowledge about warfarin and their access to warfarin education. 
It highlights the importance of older patients’ knowledge about warfarin in relation to 
therapeutic outcomes; the level of their knowledge about warfarin therapy; the 
demographic factors which may influence their knowledge about warfarin; older patients’ 
access to warfarin education in different practice settings, as well as education strategies 




A ‘quasi-systematic’ review  (i.e., a review that often attends to some details of a truly 
systematic review but misses the essential spirit of critical analysis22) of the recent 
literature regarding patient education about warfarin therapy was performed on the 
following  electronic databases Medline via OvidSP (1950 - present), Embase (1966 - 
present), Cumulative Index to Nursing and Allied Health Literature-CINAHL via Ebsco 
(1982 - present), International Pharmaceutical Abstracts-IPA via OvidSP (1950 - present), 
Meditext via Informit online (1995 - present) and Google Scholar were searched to 
retrieve original articles, review papers and other publications. A time span of 
approximately 20 years (1990- May 2011) was selected because it was during this time 
that many pivotal studies relating to patient education, therapeutic benefits and economic 
analyses of warfarin use in different settings were conducted.23-31 Being a quasi-systematic 
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review, the time was considered sufficient by the authors to include a comprehensive pool 
of contemporary publications. 
 
Search strategies 
A two-tiered search strategy was initially developed for the database searches. A 
generalised search was employed during Tier-1 using the keywords/MeSH headings 
‘warfarin’ and ‘oral anticoagulant’. More specific searches were then performed in Tier-2 
using a number of relevant keywords/MeSH headings such as ‘health information’, 
‘medicine information’, ‘patient education’, ‘patient counseling’, ‘medication counseling’ 
‘health education’, ‘patient information needs’, ‘information seeking behaviour’, ‘access 
to information’, ‘source of information’, ‘patient knowledge’ and ‘health knowledge’. 
Both ‘warfarin’ and ‘oral anticoagulant’ were used as search terms, however, only papers 
relating to warfarin were included for review. Other oral anticoagulants were not included 
in the review. The search was restricted to the English language, studies involving human 
subjects, patients aged 65 years or more, as well as original articles and review papers. In 
regard to the handling of review papers, which included both critical/narrative and 
systematic reviews, only the inferences drawn by the authors of the review were taken into 
account. Studies covering both simple and more complex interventions, e.g., information 
provision plus self-management were included in the review. Reference lists of papers 
included in this critical review were also searched for potentially missed articles. For all 
the selected papers, full texts were retrieved and were verified following the review 
objectives. The literature search, data extraction and evaluation were principally 
conducted by the research pharmacist. However, the review procedure was verified by two 




Literature retrieval and characteristics of patient population 
A total of 62 articles were reviewed and the relevant data extracted. A more detailed 
schematic representation of the article selection is indicated in Figure 1.  
[insert Figure 1 here] 
 
Within the 55 original patient intervention studies reviewed, 36 were conducted in 
community settings and the other 19 in hospital-based settings. A total of 14,541 older 
patients were identified as study participants, comprising 51.4% (n=7,470) from 
community settings and 48.6% (n=7,071) from hospital settings. Two studies pertaining to 
evaluations of patient information resources did not include human subjects but rather 
assessed warfarin information brochures only, hence these were not taken into account 
when calculating the total patient numbers.  
 
Importance of knowledge about warfarin in relation to effective therapeutic outcomes  
There is a general consensus in the literature that improved patient knowledge about 
warfarin therapy improves therapeutic outcomes.8, 11, 32-41 Kagansky et al.8 showed that 
older patients (N=323) with better knowledge about their warfarin therapy (measured by a 
non-validated warfarin knowledge-testing questionnaire) had 45% of their INR values 
within the therapeutic range, as compared with patients with poorer knowledge (35%); 
p<0.001. Tang et al.,35 also reported a weak but positive correlation between patients’ 
knowledge of warfarin therapy and the number of INR values that were within the target 
range (p=0.024). These findings were supported by another study11, which reported that 
older patients (N=125) who possessed a better understanding of warfarin therapy spent 
about 70% of the time within the therapeutic INR range, as compared to those with a 
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poorer understanding (63%). The results of this latter study however, were not statistically 
significant, reflecting the large amount of variability (e.g., in concordance, and in 
perceived benefits and barriers of warfarin therapy) within each group and also possibly 
due to the limited number of patients included. Interestingly, evidence from other studies, 
such as Davis et al., (N=52),42 The Newcastle Anticoagulation Study Group (N=242),43 
Arnsten et al., (N=132),44 Fang et al. (N=179)45 and Baker et al.,(N=260)46 suggested  no 
association between patients’ warfarin knowledge and anticoagulation control. Results of 
these latter studies, however, cannot be generalised because of their use of small sample 
sizes,42, 44, 45 retrospective and/or cross-sectional data evaluation techniques,42-45 limited 
number of variables relating to patient knowledge measured42 and use of  non-
standardised  data collection techniques.46 
 
Another important issue with regard to warfarin knowledge and therapeutic outcomes 
identified in this review was the inverse relationship between individual patient's level of 
knowledge about warfarin and the rate of adverse outcomes.8, 35, 47-49 In relation to adverse 
events, specifically haemorrhage, Pernod et al’s study48 reported significantly less 
bleeding events (n=3, 1.9%) in the patients who had better knowledge about warfarin 
compared to those patients who had a poor level of knowledge (n=12, 8.5%); p=0.01. 
Similarly, Kagansky et al.,8 found that the rate of major bleeding events was highest 
amongst patients who had poor knowledge about warfarin , reporting 5.2 bleeding 
events/1000 patient-months, compared to only 0.5 bleeding events/1000 patient-months 
among the patients who had  satisfactory knowledge (p<0.001). Beyth et al.,50 also showed 
the positive effects of patient knowledge in clinical outcomes, reporting a reduction in 
hospitalisations among patients receiving structured warfarin education compared to those 
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in a control group (3 versus 9 hospitalisations, respectively out of a total of 12 
hospitalisations; p=0.08). 
 
Deficiencies in patient knowledge about basic aspects of warfarin therapy 
Evidence from the review suggests older patients’ knowledge about their warfarin therapy 
is generally poor, with between 50-80% of patients having little knowledge about 
important basic aspects.19, 34, 35, 37, 38, 42, 43, 47, 49, 51-57 It is important, however, to highlight 
that non-validated and purpose-built warfarin knowledge-testing instruments were used in 
many of the studies 37, 47, 49, 52, 54, 56, 58-60  when assessing patient knowledge about warfarin, 
unlike the recent studies conducted by Winans et al. (2010)61 and Baker et al. (2011)46. 
 
A United Kingdom (UK) study54 revealed that as many as 81% of patients (n=93) 
receiving warfarin therapy had no knowledge about its benefits with regard to the 
treatment of their medical condition. Further, evidence from this review indicates that 
between 45% and 70% of older patients on warfarin therapy had insufficient knowledge 
about the potential risks associated with their treatment.49, 54, 58-60, 62 Other studies 
highlighted that only between 15% and 57% of the older patients knew their own INR 
targets or therapeutic ranges.47, 54, 63 Also, Lane et al.,54 found that approximately 63% of 
them were unaware of  factors such as other medications and diet, which could affect their 
INR levels.  
 
This review also found that older patients’ knowledge about potential drug/food 
interactions with warfarin was poor, with as many as 60-80% of the patients being 
unaware that such interactions could occur.37, 42, 47, 63 Notably, between 22% and 49% of 
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older patients receiving warfarin therapy were unaware of the restrictions of alcohol use 
required when taking warfarin.49, 52, 56  
 
Interestingly, Baker et al.,46 in a single centre, cross-sectional study showed that 74% 
(N=185) of patients receiving long-term warfarin therapy had achieved a good warfarin 
knowledge score (78%) based on  the validated 29-point Anticoagulation Knowledge 
Assessment (AKA) instrument. They did however, suggest that the score may have been 
inflated because of the self-completed questionnaire completed at home with possible 
assistance from others.  
 
Demographic factors influencing patients’ knowledge about warfarin  
According to the evidence in this review, it appears that increasing age negatively impacts 
upon both knowledge about warfarin therapy35, 47 and the retention of warfarin information 
over time.36, 64 In their study, Tang et al.,35 found that the mean warfarin knowledge scores 
(out of a possible total score of 1.0) declined with advancing age; <65 years olds scored 
0.47; 65-74 year olds scored 0.44; and >75year olds scored 0.39. Similarly, McCabe et 
al.,47 found that patients aged between 65-74 years had knowledge scores of 26.6 (out of a 
possible 50), as compared to 19.1 for those aged between 75-94 years; p=0.001.  
 
Unlike gender, which was not found to influence patients’ knowledge about their warfarin 
therapy,34, 35, 47 various socio-demographic factors such as lower family income, limited 
health literacy, unemployment status and lower education levels appeared to negatively 
influence patients’ knowledge.34, 35, 45, 47, 53, 58-60, 65, 66 Hu et al.34, reported that patients who 
had an annual family income of less than US$25,000 achieved significantly lower 
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knowledge scores compared to patients who had higher family incomes (knowledge score 
13.1 vs. 14.7 out of a total of 20; p=0.007).  
 
There is very limited data regarding the influence of ethnicity on knowledge about 
warfarin. A small number of studies59, 60, 66 highlighted that knowledge about warfarin is 
suboptimal among ethnic patients who are immigrants in English-speaking countries; 
however, older age and low educational status (contributing to low health literacy) appear 
to be more significant influences on knowledge than ethnicity per se in these patients. A 
key issue arising from studies involving ethnically diverse patient groups is a perceived 
lack of engagement in decision-making processes regarding warfarin therapy because 
patients are unable to fully comprehend the information (due to language barriers) 
provided verbally during health consultations.59, 66 
 
Access to warfarin education for patients in different clinical practice settings 
The review found that provision of warfarin education and/or information in both 
community and hospital settings was inadequate, i.e., a small proportion of patients 
received warfarin education8, 19, 35, 67 or unsatisfactory warfarin education (i.e., a  lack of 
appropriate information or a lack of clarity of the information) for those older patients 
who had received information about warfarin.8, 53 
 
Access to warfarin education for patients in the community settings 
 Overall, the provision of warfarin education for patients in community settings is 
generally considered to be inadequate in terms of accessibility to both information sources 
and resources.16, 35, 49, 52 This review found that the majority (between 45% to 88%) of 
older patients in community settings regarded their treating physicians as the main sources 
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of information about their warfarin therapy,35, 52, 63 This is supported by a recent Australian 
study18 which found that  only 39% (n=36) of GPs considered that it was their 
responsibility to deliver warfarin education to their patients. The review also found that a 
comparatively small proportion of patients indicated pharmacists (0.8-27%)17, 35, 52, 68 and 
nurses (1.6-50%)35, 52, 68 as their major sources of information about warfarin therapy. This 
represents an underutilization of the available resources of warfarin educators because 
patients often have limited access to their GP, who may not have prioritised discussing 
warfarin therapy during their consultations times.53   
 
Currently, many older patients in community settings are being treated by anticoagulation 
services, which provide a wide range of services such as INR monitoring, warfarin dosage 
adjustment and, supposedly, ongoing education about their warfarin therapy.11, 35 Despite 
the common perception, that these patients receive superior education about their warfarin 
therapy,60 between 17% and 35% of them still do not receive any education about basic 
aspects of their warfarin therapy.49, 69 
 
Factors that may contribute to inadequate patient education for older patients about 
warfarin in the community setting include time constraints, availability of resources and 
cognitive decline in old age.  Other factors are beyond the control of healthcare providers, 
such as: poor patient recall, learning difficulties of older patients due to age-related 
cognitive impairments and patient complacency  may have contributed to information 
deficits in this setting or, for that matter, any other setting.16, 60 
 
Access to warfarin education for hospital in-patients  
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This review also suggests that patient education about warfarin in the hospital setting is 
also inadequate.16, 57, 69 Kagansky et al.,8 and Cheah et al.,19 identified that between 16% 
and 61% of hospital in-patients reported not having received any warfarin education 
during their hospital stay. On discharge from hospital, only 30-57% of patients reported 
having received any type of warfarin information from hospital-based health professionals 
(including doctors).19, 70  Kagansky et al.,8  found that only 21% of patients who received 
in-hospital warfarin education considered it to have been ‘satisfactory’. The factors 
contributing to the satisfaction with the warfarin education were mostly related to the 
amount, content, clarity and usefulness of information provided to patients.8, 67 
 
Education strategies for improving older patients’ knowledge about warfarin  
In recognition of the reported knowledge deficits, several structured and interventional 
education strategies (e.g., individualised face-to-face verbal consultations, group-based 
patient education and other) about warfarin have been evaluated and reported in the 
literature.11, 38, 50, 54, 64, 67, 71  These strategies are described as follows: 
 
Individual face-to-face patient education session  
Interventions and strategies to improve the education of patients taking warfarin have, to 
date, largely focussed on providing individual face-to-face counselling by key healthcare 
professionals within their respective practice settings, e.g., GPs counselling patients in 
their surgeries or community pharmacists counselling their customers in their 
pharmacies.35, 48, 54, 67 This mode of education is most often used because it is convenient, 
easy to deliver and allows the educator to target the patient’s individual needs.36, 38, 71  
 
Group-based warfarin education session 
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In resource-limited and time-poor health care systems and environments, e.g., 
anticoagulation clinics and hospital settings, where provision of individual face-to-face 
education sessions is difficult, practical and sustainable alternative modes of education 
may be considered. These alternative modes may include group-based sessions, rather 
than individual-based sessions, as well as the use of pre-recorded information sessions, 
such as videos.64, 71 Group-based education sessions have been successfully implemented 
in environments where it is feasible to convene a group of patients, such as in a hospital 
and/or in anticoagulation clinics.11, 38, 71 In addition to the time-saving advantage of group-
based education approaches, other advantages include patient-peer support and the 
opportunity to learn from their peers about alternative aspects of their therapy.16  
However, it is also important to consider the limitations of group-based education sessions 
which include the difficulty in scheduling the group session and inability to meet 
individual information needs.71  
 
Written information for warfarin education 
The review identified that written warfarin information resources, available as both 
printed materials and via the internet, could not be read or understood by between 50% to 
88% of the older patient population.58, 72 Bajorek et al.,16 further reported that both health 
professionals and patients perceived existing written information materials to be 
suboptimal in terms of content regarding day-to-day warfarin management issues, e.g., 
interactions with other drugs or foods. Given the suboptimal nature of existing warfarin-
related written information materials,16 various strategies have been suggested in the 
reviewed literature to improve the comprehensibility and usability of these materials.  
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The use of specially designed written materials that contain relevant figures or images, 
pictograms, larger font or page size and other formatting elements which could improve 
the comprehensibility of written materials, especially for older patients, have all been 
proposed in the literature.35, 48, 72 The use of cue cards that contain short but important 
pieces of information was similarly suggested.55 This approach may help deliver lengthy 
and time-consuming information more efficiently and may also provide patients with 
ample time to process the information during an education session.16, 55 Although these 
could help in tailoring written materials for older patients receiving warfarin therapy, to 
date, no information about the practical uses of these different strategies has been found in 
the literature.  
 
Audiovisual resources for warfarin education 
Audiovisual media that portray the healthcare professional ‘talking’ to the patient about 
their warfarin therapy are sometimes used as a lateral extension of conventional patient 
education interventions.64 This pre-recorded, multi-media face-to-face counselling 
disseminates information to patients in any treatment setting, including their own homes. 
As an added advantage, this mode of patient education can be repeated at the patient’s 
convenience without burdening the healthcare professional. The flexibility and resource-
efficiency offered by this approach is obvious.64 The wider use of video-based patient 
education resources may be restricted by the need for specific equipment to play the 
videos/DVDs and/or operational skills, suggesting the need for exploring other 
audiovisual media such as public television (given its effectiveness in other areas of 
medicine).16, 64 The potential of this media as a resource is acknowledged in an Australian 
study,16 where healthcare professionals involved in the management of warfarin therapy 
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recommended the use of television campaigns for educating patients, particularly 
regarding the prevalent misconceptions regarding warfarin therapy.  
 
Basic aspects in warfarin education programmes 
Integral to effective warfarin education programmes is the inclusion of a minimum set of 
basic aspects targeting patient knowledge and understanding about warfarin therapy, 
irrespective of who is providing the education (e.g. doctor, pharmacist, nurse).71, 73 These 
basic aspects include: the name of the medicine, mode of action, adverse events, 
interactions with other drugs or foods, issues related to INR monitoring, the importance of 
good adherence, lifestyle behavioural adjustments and managing emergency situations 
such as missed or under/over doses and recognising signs of bleeding complications.11, 35, 
38, 48, 50, 54, 67, 71 Importantly, while some of the reviewed education programmes have 
included a majority of these aspects,38, 48, 67 others focused primarily on just a few.35, 50, 71 
In most cases, the selection and inclusion of the basic information about warfarin within 
patient education programmes was primarily decided by the healthcare personnel 
providing the education.35, 50, 64, 67, 71 It is noteworthy that generally the selection and 
inclusion of the basic aspects of warfarin within the education programmes is inconsistent 
and varies from one program to another. 
 
Effects of education interventions on the level of control of therapy and outcomes by 
improving patient knowledge 
Various interventions11, 48, 54, 63, 64, 71 have been developed and trialled on patients in order 
to evaluate their impact on the level of control of therapy and outcomes through improved 
warfarin education for patients. In a UK-based study,54 patients who received a structured 
education session had significant knowledge gains particularly regarding understanding 
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INR targets (67% patients vs. 56% at baseline, p=0.001) and factors affecting INR values 
(58% patients vs. 37% at baseline, p=0.014) when compared with their baseline 
knowledge status. In this study, patients from an anticoagulation clinic received 
individualised, face-to-face education from their treating doctors along with a purpose-
designed warfarin booklet. Further, in a multi-centre study,48 patients from both 
community and hospital settings who received a specifically-designed individualised 
education programme (including face-to-face verbal consultation from members of a 
multidisciplinary team, a picture book describing the disease and treatment and a specific 
booklet summarizing the information) achieved higher mean warfarin knowledge scores 
(13.9 out of a total score of 20), when compared to the control group (mean score 12.4), 
who received unstructured warfarin counselling sessions(p=0.08). The latter study48 also 
reported a statistically significant (p<0.01) cumulative risk reduction in major bleeding 
events in the experimental group who had received warfarin education. 
 
In a United States (USA)-based study,71 180 anticoagulation, clinic-based patients were 
educated in groups of 15 by either a pharmacist or a nurse via an hour-long slide 
presentation. The study showed that significantly more patients had better knowledge 
about the important aspects of warfarin therapy after the intervention, particularly about 
the importance of the INR test (91% patients vs. 36% at baseline; p<0.001) and effects of 
vitamin K on the therapy (96% patients vs. 49% at baseline; p<0.001), as compared to 
their baseline knowledge about warfarin. Further, Khan et al.,11 demonstrated a significant 
decline in the INR SD (standard deviation) by 0.26 (p<0.0001) in the group receiving 
education alone, 0.24 (p<0.0001) in the group allocated to education and self-monitoring, 
and 0.16 (p=0.003) in the control group who had received usual care. However, intergroup 
comparisons showed no statistically significant difference in the decline of INR SD 
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(intervention groups 0.25 vs. control group 0.16; p=0.12), which may be because of firstly, 
the large amount of variability within each group (e.g., in concordance and in perceived 
benefits and barriers of warfarin therapy) and secondly, possibly due to the limited 
number of patients that were studied.  
 
Mazor et al.,64 showed that 317 intervention patients (56% of whom were aged 65 years 
and older) who received and watched mailed copies of videos in their homes, depicting a 
virtual face-to-face patient education session about warfarin management (unknown 
length and duration), had significant knowledge gains measured by knowledge-testing 
questionnaires (68% correct answers of the total 22 questions) when compared to the 




The main focus of this review paper was to highlight the level of, and access to, warfarin 
education/information and the effects of existing warfarin education interventions on 
patient knowledge and therapeutic outcomes.  
 
The complexity of warfarin therapy is such that the patients’ command of anticoagulation-
related knowledge is a very important component in maintaining optimal control of the 
therapy and reducing related adverse events.74 This review highlights that a significant 
proportion of older patients have deficits in their knowledge regarding warfarin, although 
it is generally accepted that patients on warfarin therapy receive more comprehensive 
warfarin information from their health professionals when compared to patients taking 
other types of regular medications.62 Nevertheless, the apparent lack of adequate 
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knowledge has considerable clinical importance as it diminishes therapeutic outcomes in 
OAT, especially in the more vulnerable, older patient population. Due to the use of non-
validated and purpose-built knowledge testing tools reported in the reviewed literature, it 
is difficult to judge the actual prevalence of knowledge deficits among patients receiving 
warfarin therapy. Although two validated knowledge-testing tools33, 75 have been 
identified in the literature, for reasons not stated, these have not been used in the reviewed 
articles, apart from being described as pilot studies. The authors suggest further 
investigation is warranted to determine the characteristics and actual prevalence of older 
patients’ knowledge deficits about warfarin by using validated and standard knowledge-
evaluation methods.  
 
Patients’ age35, 47 and other demographic factors such as poor family income, limited 
health literacy, unemployment, lower education levels34, 35, 45, 47, 53, 58-60, 65, 66 and, 
potentially, ethnicity to some extent59, 60, 66 have been found to negatively impact on 
patient knowledge about warfarin. The provision of additional resources such as 
audiovisual/multimedia resources (when available), pictograms, drawings and/or cue 
cards, could also be recommended to help improve their warfarin knowledge and 
understanding. These flexible delivery resources can be used to address the information 
needs of individual patients in the comfort of their own homes.  
 
On commencement of warfarin therapy, patients generally receive an unstructured, verbal 
education session from their healthcare provider, which includes the basic aspects of their 
warfarin therapy.38 In some circumstances, patients who are keen may also seek additional 
information from various other readily available sources, e.g., community pharmacist, 
nurses, the internet.34, 35 This review, however, highlights the current lack of access or 
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availability of suitable warfarin education and/or information resources in both 
community and hospital settings. In addition, an underutilisation of the available resources 
of warfarin education by patients is also apparent in this review. Inadequate provision of 
warfarin education in the hospital settings is  a concern since  a large proportion  of 
patients  commence warfarin therapy  in hospitals and  are at a tenfold risk of bleeding 
within the first month of therapy, post-discharge.19 Lack of inadequate access to warfarin 
education is a major concern for older patients who are  prescribed warfarin therapy for 
chronic conditions such as atrial fibrillation, given their susceptibility to warfarin-related 
adverse events which are further potentiated by poor knowledge about their warfarin 
therapy.16 It is, therefore, imperative that older patients in particular should be provided 
with appropriate  warfarin education and/or information sessions, reinforcement and 
follow-up76, 77 to ensure that they retain the information provided.36, 64  
 
The time or resource constraints of healthcare providers, which have the potential to 
impact upon the availability and the quality of education provided,17, 18, 21 are real and are 
often cited as a major barrier to patient education in the busy treatment settings (e.g., 
hospitals) of many developed countries such as Australia and the USA.78 For other 
developed countries (e.g., European countries), the resource implications and needs may 
be different, however this review’s exclusion criteria (i.e., non-English language) may 
have precluded access to this relevant information. A multidisciplinary approach inclusive 
of pharmacists, nurses, and dieticians could be helpful in educating patients about their 
warfarin therapy in the busy treatment settings.17   
 
For warfarin education to be effective it is generally agreed by patients and/or their carers 
that both verbal and written patient information are equally important.16 Interestingly, 
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even though this review highlighted the importance of providing simple and easy to read 
written information about warfarin, which to date appears to be generally unavailable, it 
did not identify any findings about the use of appropriate verbal communications skills 
when speaking to older patients. Given that evidence from other research79-81 has 
emphasized that effective verbal communication between health practitioners and patients 
can be achieved by incorporating simple strategies such as using simple language, 
speaking slowly, repeating and reinforcing key points by incorporating the ‘teach-back’ 
method, whereby the patient is asked to repeat back what they have heard and what it 
means to them and encouraging them to ask questions and not to give too many directives 
which may overwhelm them. It seems that this would be an important area for future 
research, especially with regard to incorporating such strategies into effective education 
programmes. 
 
The review found that both individual and group-based education sessions could 
effectively educate older patients. Given the need to offer older patients reinforcement and 
follow-up, offering group-based education in addition to individual education would be 
beneficial, particularly in resource-poor settings, such as hospital settings. In the reviewed 
literature, methodological issues arose relating to the design and mode of implementation 
of educational interventions which will require improvements. Also, given the wide 
variability of basic aspects, e.g., action, benefits and risks, interactions with other drugs or 
foods and INR management, in the existing education programmes, it is important to 
ensure that these aspects are carefully selected and included in future education 
programmes in order to inform older patients more effectively and appropriately.  
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The review encounters several limitations. Although every effort was made to include a 
comprehensive pool of relevant literature, the quasi-systematic review method may have 
excluded some potential papers from being included and the exclusion of non-English 
language papers may also have been a limitation. Further, following from the objectives of 
the review, other important issues relevant to anticoagulation management, e.g., self-
management or monitoring by patients, medication adherence and anticoagulation control, 




Patient education and relevant resources are currently applied in an ad hoc manner in all 
facets of education about warfarin. It is, however, timely and important now to identify, 
target and develop (where appropriate) effective educational materials and resources and 
to incorporate them into an educational strategy that improves knowledge and therapeutic 
outcomes in warfarin therapy, especially amongst the older patient population. Based on 
the literature reviewed, a number of practice points have been outlined (Box 1), to help 
practitioners improve the education of older persons about their warfarin. 
[insert Box 1 here] 
Conclusion 
Overall, older patients’ knowledge about the basic aspects of warfarin therapy is 
inadequate, which is compounded by limited access to existing warfarin education 
services in both community and hospital settings. The provision of more structured 
warfarin education (both individual and group sessions) with additional resources, such as 
web-based audio-visual aides, could be used to improve warfarin knowledge and 
understanding amongst older patients.  
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Box 1: Potential practice points that may help practitioners improve the education of 






 Socio-demographic factors, which can negatively impact on warfarin knowledge and understanding, 
need to be taken into consideration when developing warfarin education programmes. These factors 
include older patients, low income, unemployment status, low education levels, poor health literacy 
skills and, possibly, ethnicity.  
 
 Provision of adequate and appropriate warfarin education services to patients may require 
coordinated efforts from all health professionals, e.g., doctors, pharmacists, nurses, to ensure that 
patient education is provided consistently and in a structured format. Also, all patients commenced 
on warfarin therapy, in particular hospital in-patients, should have access to follow-up services 
within the community. 
 
 Warfarin education programmes, both individual and group-based), need to be comprehensive and 
systematically cover the key aspects of warfarin therapy. These key aspects should consist of; name 
of the medicine, purpose of the therapy (including the risks versus benefits), mode of action, adverse 
events, interactions with other drugs or foods, issues related to INR monitoring, the importance of 
good adherence, lifestyle behavioural adjustments and management of emergency situations, e.g., 
missed or under/over doses and recognising signs of bleeding complications. 
 
 Warfarin education resources may be most effective when they include simple and easy to 
understand written information, taking into account readability of the information, as well as 
presentation, as a supplement to verbal counselling, and purpose-designed additional  
communication tools such as cue cards, audiovisual resources depicting real-life scenarios and/or 
socio-culturally appropriate  images/figures, e.g., pictograms/drawings, video tapes/DVDs, online 
videos, podcasts, television programmes, internet sites.  
